COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Systane Clinical Experience Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00818909
Recruitment Status : Completed
First Posted : January 8, 2009
Last Update Posted : February 2, 2012
Information provided by (Responsible Party):
Alcon Research

Brief Summary:
To evaluate the physical effect of SYSTANE QID in people that have moderate to severe dry eyes and to establish doctor confidence to prescribe Systane.

Condition or disease Intervention/treatment Phase
Dry Eye Syndrome Other: Systane Phase 4

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 941 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Study to Evaluate the Physical Effect of SYSTANE QID in People That Have Moderate to Severe Dry Feeling Eyes
Study Start Date : January 2009
Actual Primary Completion Date : October 2009
Actual Study Completion Date : October 2009

Resource links provided by the National Library of Medicine

Drug Information available for: Systane

Arm Intervention/treatment
Experimental: Systane
Systane ocular product
Other: Systane
Systane prescription

Primary Outcome Measures :
  1. corneal and conjunctiva staining score [ Time Frame: 4 weeks ]

Secondary Outcome Measures :
  1. Tear film break up time [ Time Frame: 4 weeks ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • moderate to severe dry feeling eyes

Exclusion Criteria:

  • None
Layout table for additonal information
Responsible Party: Alcon Research Identifier: NCT00818909    
Other Study ID Numbers: CARES-3
First Posted: January 8, 2009    Key Record Dates
Last Update Posted: February 2, 2012
Last Verified: January 2012
Keywords provided by Alcon Research:
Dry eye
Moderate to severe dry eye
Additional relevant MeSH terms:
Layout table for MeSH terms
Dry Eye Syndromes
Eye Diseases
Lacrimal Apparatus Diseases